Quantitative Imaging Articles & Analysis
9 news found
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the launch of its new 3D Tissue Imaging Services to researchers with comprehensive solutions for 3D imaging of tissues, including 3D Immunolabeling, Tissue Removal, 3D Imaging, and Quantitative ...
Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...
“I always wanted to move the radiological approach from an art to a science,” he says. Focusing on the quantitative information available in images can provide a key to unlocking this vision. ...
ByFluidda
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). ...
ByFluidda
In addition, VIDA is continuously innovating through partnerships with pulmonary leaders to advance new multi-modality imaging biomarkers.” VIDA is announcing multiple new chest imaging biomarkers, available for both prospective clinical trials and retrospective datasets. These latest imaging biomarkers strengthen VIDA’s portfolio of ...
” De Backer further explains, “We can also measure the resistance in the airways from the images and look at the deposition of inhaled products and ...
ByFluidda
VERITON-CT64 SPECT/CT digital technology plus unique design enables routine hybrid 3D imaging for cardiac, brain, lung indications, and for the first time, total body hybrid SPECT/CT imaging. Head to toes SPECT/CT scan in less than 20 minutes: avoids the additional scanning that is needed when planar imaging is used for whole-body scans. Easy on ...
“Quantitative imaging of the airways, for example with functional respiratory imaging (FRI), is evolving from a research tool towards clinical applications” ,Dr. ...
ByFluidda
Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and ...
ByAidoc